Heart Attack
A heart attack, or acute myocardial infarction (AMI), occurs when blood flow to a part of the heart is blocked, causing damage to the heart muscle. This can lead to severe complications if not treated promptly.
We are studying whether self-administering selatogrel can help prevent further heart attacks in individuals with a recent heart attack history. The trial also looks at the safety of this self-administration.
Health conditions and diseases that the clinical trial is designed to study and treat.
A heart attack, or acute myocardial infarction (AMI), occurs when blood flow to a part of the heart is blocked, causing damage to the heart muscle. This can lead to severe complications if not treated promptly.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.